Sep 13, 2021 / 11:00AM GMT
Andrew S. Fein - H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst
Hello, everyone. I'm Andrew Fein. I'm one of the biotechnology analysts at H.C. Wainwright. It's my pleasure to introduce the next company presenting at the conference, which is Cortexyme. Presenting for the company will be its CEO and CFO, Casey Lynch and Chris Lowe, respectively.
So with that, Casey, I wanted to just take a couple of minutes to introduce yourself, introduce the company. And then from there, we can go into specific questions.
Casey C. Lynch - Cortexyme, Inc. - Co-Founder, Chairman, President & CEO
Yes. Great to be here, Andrew. I'm Casey Lynch, Co-Founder and CEO. I'm an entrepreneur with a background in Alzheimer's research. I've been very focused on understanding a comprehensive hypothesis of Alzheimer's disease throughout my career. So I'm very excited to be reaching a pivotal moment in milestones for Cortexyme. We're a few months away from a pivotal readout in a Phase III study in mild-to-moderate Alzheimer
Cortexyme Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot